HP INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) | |||||
Three months ended October 31, | |||||
2018 | 2017 | ||||
Cash flows from operating activities: | |||||
Net earnings | $ | 1,451 | $ | 660 | |
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
Depreciation and amortization | 140 | 91 | |||
Stock-based compensation expense | 65 | 55 | |||
Restructuring and other charges | 40 | 113 | |||
Deferred taxes on earnings | (486) | (174) | |||
Other, net | 85 | 65 | |||
Changes in operating assets and liabilities, net of acquisitions: | |||||
Accounts receivable | (514) | (238) | |||
Inventory | (15) | (615) | |||
Accounts payable | 519 | 423 | |||
Taxes on earnings | (412) | 318 | |||
Restructuring and other | (30) | (78) | |||
Other assets and liabilities | 125 | 60 | |||
Net cash provided by operating activities | 968 | 680 | |||
Cash flows from investing activities: | |||||
Investment in property, plant and equipment | (187) | (165) | |||
Proceeds from sale of property, plant and equipment | 62 | — | |||
Purchases of available-for-sale securities and other investments | (47) | (362) | |||
Maturities and sales of available-for-sale securities and other investments | 259 | 229 | |||
Collateral posted for derivative instruments | (24) | (372) | |||
Collateral returned for derivative instruments | 24 | 676 | |||
Net cash provided by investing activities | 87 | 6 | |||
Cash flows from financing activities: | |||||
Payment of short-term borrowings with original maturities less than 90 days, net | (834) | (844) | |||
Payment of short-term borrowings with original maturities greater than 90 days | (412) | — | |||
Proceed from short-term borrowings with original maturities greater than 90 days | — | 887 | |||
Payment of debt | (39) | (22) | |||
Net proceeds related to stock-based award activities | 18 | 45 | |||
Repurchase of common stock | (598) | (501) | |||
Cash dividends paid | (219) | (221) | |||
Net cash used in financing activities | (2,084) | (656) | |||
(Decrease) Increase in cash and cash equivalents | (1,029) | 30 | |||
Cash and cash equivalents at beginning of period | 6,195 | 6,967 | |||
Cash and cash equivalents at end of period | $ | 5,166 | $ | 6,997 | |
HP INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) | |||||
Twelve months ended October 31, | |||||
2018 | 2017 | ||||
Cash flows from operating activities: | |||||
Net earnings | $ | 5,327 | $ | 2,526 | |
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
Depreciation and amortization | 528 | 354 | |||
Stock-based compensation expense | 268 | 224 | |||
Restructuring and other charges | 132 | 362 | |||
Deferred taxes on earnings | (3,653) | 238 | |||
Other, net | 319 | 134 | |||
Changes in operating assets and liabilities, net of acquisitions: | |||||
Accounts receivable | (491) | (453) | |||
Inventory | (136) | (1,346) | |||
Accounts payable | 1,429 | 2,161 | |||
Taxes on earnings | 389 | 73 | |||
Restructuring and other | (237) | (233) | |||
Other assets and liabilities | 653 | (363) | |||
Net cash provided by operating activities | 4,528 | 3,677 | |||
Cash flows from investing activities: | |||||
Investment in property, plant and equipment | (546) | (402) | |||
Proceeds from sale of property, plant and equipment | 172 | 69 | |||
Purchases of available-for-sale securities and other investments | (367) | (1,400) | |||
Maturities and sales of available-for-sale securities and other investments | 847 | 231 | |||
Collateral posted for derivative instruments | (1,165) | (1,170) | |||
Collateral returned for derivative instruments | 1,379 | 955 | |||
Payments made in connection with business acquisitions, net of cash acquired | (1,036) | — | |||
Net cash used in investing activities | (716) | (1,717) | |||
Cash flows from financing activities: | |||||
Proceeds from short-term borrowings with original maturities less than 90 days, net | 743 | 202 | |||
Proceeds from short-term borrowings with original maturities greater than 90 days | 712 | 887 | |||
Proceeds from debt, net of issuance cost | — | 5 | |||
Payment of short-term borrowings with original maturities greater than 90 days | (1,596) | (3) | |||
Payment of debt | (2,098) | (84) | |||
Settlement of cash flow hedge | — | (9) | |||
Net proceeds related to stock-based award activities | 52 | 57 | |||
Repurchase of common stock | (2,557) | (1,412) | |||
Cash dividends paid | (899) | (894) | |||
Net cash used in financing activities | (5,643) | (1,251) | |||
(Decrease) Increase in cash and cash equivalents | (1,831) | 709 | |||
Cash and cash equivalents at beginning of period | 6,997 | 6,288 | |||
Cash and cash equivalents at end of period | $ | 5,166 | $ | 6,997 | |